<DOC>
	<DOCNO>NCT02451358</DOCNO>
	<brief_summary>The aim study generate immunogenicity safety data whole population support registration Quadrivalent Influenza Vaccine ( QIV ) India : Primary objective : - To describe age group immune response induce single injection ( subject age &gt; 9 year ) 2 injection ( subject age 6 month 8 year ) QIV . Secondary objective : - To describe age group safety profile QIV .</brief_summary>
	<brief_title>Study Single Dose Two Doses Quadrivalent Influenza Vaccine Subjects Aged 6 Months Older India</brief_title>
	<detailed_description>All participant vaccinate quadrivalent influenza vaccine ( QIV ) ( split-virion , inactivate ) Northern Hemisphere ( NH ) 2014-2015 formulation intramuscular ( IM ) route . Immunogenicity vaccine assess baseline ( Day 0 ) 28 day last injection . Safety data collect 28 day vaccination . Serious adverse event ( SAEs ) , include adverse event special interest ( AESIs ) collect throughout trial .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 6 month old day inclusion For subject age 6 35 month : bear full term pregnancy ( ≥37 week ) birth weight ≥2.5 kg Informed consent form sign dated subject / subject ' parent ( ) another legally acceptable representative independent witness , require local regulation . For subject age 7 17 year age , assent form sign dated subject . Subject / subject ' parent/legally acceptable representative able attend schedule visit comply trial procedure . Subject pregnant , lactating , childbearing potential ( consider nonchildbearing potential , female must premenarche postmenopausal least 1 year , surgically sterile , use effective method contraception abstinence least 4 week prior vaccination least 4 week vaccination ) Participation time study enrollment ( 4 week precede first trial vaccination ) plan participation present trial period another clinical trial investigate vaccine , drug , medical device , medical procedure Receipt vaccine 4 week precede first trial vaccination plan receipt vaccine 4 week follow trial vaccination ( except oral poliomyelitis vaccine ( OPV ) receive national immunization day ) For subject age 9 year old : previous vaccination influenza ( previous 6 month ) either trial vaccine another vaccine For subject age 6 month 8 year : previous prim influenza vaccine ( i.e. , subject receive two dos last influenza season one dose time last season ) Receipt immune globulin , blood bloodderived product past 3 month Known suspected congenital acquire immunodeficiency ; receipt immunosuppressive therapy , anticancer chemotherapy radiation therapy , within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Selfreported history seropositivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B , Hepatitis C , question Known systemic hypersensitivity vaccine component , history lifethreatening reaction vaccine ( ) use trial vaccine contain substance Selfreported thrombocytopenia report parent/legally acceptable representative , contraindicate intramuscular ( IM ) vaccination Bleeding disorder , receipt anticoagulant 3 week precede inclusion , contraindicate IM vaccination Deprived freedom administrative court order , emergency setting , hospitalize involuntarily For subject age 9 year old : current alcohol abuse drug addiction Chronic illness , opinion investigator , stage might interfere trial conduct completion Moderate severe acute illness/infection ( accord investigator judgment ) day vaccination febrile illness ( axillary temperature ≥ 38.0°C ) . A prospective subject include study condition resolve febrile event subside Identified Investigator employee Investigator study center direct involvement propose study , identify immediate family member ( i.e. , parent , spouse , natural adopt child ) Investigator employee direct involvement propose study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Quadrivalent Inactivated Influenza Vaccine ( QIV )</keyword>
</DOC>